Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Operational Challenges of Neuroscience Clinical Trials, Part 2: High Placebo Responses By Krista Armstrong August 21, 2018 Clinical ResearchPhase 1 - Phase 4 5 Must-Dos To Build Trust Between an Early-Stage Biotech and CRO By Premier Research August 16, 2018 Clinical ResearchPhase 1 - Phase 4 Operational Challenges of Neuroscience Clinical Trials, Part 1: Overview By Krista Armstrong August 14, 2018 Medical and Regulatory Affairs The Ongoing Quest for Evidence on the Health Effects of Cannabis and Cannabis-Derived Products By Premier Research August 9, 2018 Medical and Regulatory Affairs Current Challenges (and Solutions) in Global Regulatory Harmonization By Premier Research August 7, 2018 Medical and Regulatory Affairs State of the Nation: Cannabis-Based Therapies By Premier Research August 2, 2018 Previous 1 …28 29 30 31 32 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today